Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1993 2
1994 2
1995 2
1999 1
2001 1
2003 2
2005 1
2007 1
2008 6
2009 5
2010 4
2011 7
2012 6
2013 8
2014 8
2015 12
2016 14
2017 14
2018 26
2019 18
2020 22
2021 41
2022 20
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Robichaux JP, Le X, Vijayan RSK, Hicks JK, Heeke S, Elamin YY, Lin HY, Udagawa H, Skoulidis F, Tran H, Varghese S, He J, Zhang F, Nilsson MB, Hu L, Poteete A, Rinsurongkawong W, Zhang X, Ren C, Liu X, Hong L, Zhang J, Diao L, Madison R, Schrock AB, Saam J, Raymond V, Fang B, Wang J, Ha MJ, Cross JB, Gray JE, Heymach JV. Robichaux JP, et al. Among authors: vijayan rsk. Nature. 2021 Sep;597(7878):732-737. doi: 10.1038/s41586-021-03898-1. Epub 2021 Sep 15. Nature. 2021. PMID: 34526717 Free PMC article.
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Elamin YY, Robichaux JP, Carter BW, Altan M, Tran H, Gibbons DL, Heeke S, Fossella FV, Lam VK, Le X, Negrao MV, Nilsson MB, Patel A, Vijayan RSK, Cross JB, Zhang J, Byers LA, Lu C, Cascone T, Feng L, Luthra R, San Lucas FA, Mantha G, Routbort M, Blumenschein G Jr, Tsao AS, Heymach JV. Elamin YY, et al. Among authors: vijayan rsk. Cancer Cell. 2022 Jul 11;40(7):754-767.e6. doi: 10.1016/j.ccell.2022.06.006. Cancer Cell. 2022. PMID: 35820397 Free PMC article. Clinical Trial.
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Robichaux JP, Elamin YY, Vijayan RSK, Nilsson MB, Hu L, He J, Zhang F, Pisegna M, Poteete A, Sun H, Li S, Chen T, Han H, Negrao MV, Ahnert JR, Diao L, Wang J, Le X, Meric-Bernstam F, Routbort M, Roeck B, Yang Z, Raymond VM, Lanman RB, Frampton GM, Miller VA, Schrock AB, Albacker LA, Wong KK, Cross JB, Heymach JV. Robichaux JP, et al. Among authors: vijayan rsk. Cancer Cell. 2019 Oct 14;36(4):444-457.e7. doi: 10.1016/j.ccell.2019.09.001. Epub 2019 Oct 3. Cancer Cell. 2019. PMID: 31588020 Free PMC article. Clinical Trial.
Hemorphins Targeting G Protein-Coupled Receptors.
Ayoub MA, Vijayan R. Ayoub MA, et al. Among authors: vijayan r. Pharmaceuticals (Basel). 2021 Mar 7;14(3):225. doi: 10.3390/ph14030225. Pharmaceuticals (Basel). 2021. PMID: 33799973 Free PMC article. Review.
Piezoelectric Ultrasound Rhinoplasty.
Singh P, Dhar S, Singh E, Vijayan R, Mosahebi A. Singh P, et al. Among authors: vijayan r. Aesthet Surg J. 2020 Jan 29;40(2):NP63-NP64. doi: 10.1093/asj/sjz279. Aesthet Surg J. 2020. PMID: 31995178 No abstract available.
Antioxidant and anticancer properties of berries.
Baby B, Antony P, Vijayan R. Baby B, et al. Among authors: vijayan r. Crit Rev Food Sci Nutr. 2018;58(15):2491-2507. doi: 10.1080/10408398.2017.1329198. Epub 2017 Aug 14. Crit Rev Food Sci Nutr. 2018. PMID: 28609132 Review.
Spices: Potential Therapeutics for Alzheimer's Disease.
Satheeshkumar N, Vijayan RS, Lingesh A, Santhikumar S, Vishnuvardhan Ch. Satheeshkumar N, et al. Among authors: vijayan rs. Adv Neurobiol. 2016;12:57-78. doi: 10.1007/978-3-319-28383-8_4. Adv Neurobiol. 2016. PMID: 27651248 Review.
Interaction of hemorphins with ACE homologs.
Jobe A, Antony P, Altabbal S, Al Dhaheri Y, Vijayan R. Jobe A, et al. Among authors: vijayan r. Sci Rep. 2023 Mar 6;13(1):3743. doi: 10.1038/s41598-023-30771-0. Sci Rep. 2023. PMID: 36878973 Free PMC article.
Molecular basis of the therapeutic properties of hemorphins.
Ali A, Alzeyoudi SAR, Almutawa SA, Alnajjar AN, Vijayan R. Ali A, et al. Among authors: vijayan r. Pharmacol Res. 2020 Aug;158:104855. doi: 10.1016/j.phrs.2020.104855. Epub 2020 May 11. Pharmacol Res. 2020. PMID: 32438036 Review.
218 results